Skip to main content
. 2021 Oct 19;16(10):e0258754. doi: 10.1371/journal.pone.0258754

Table 3. Demographic and clinical characteristics of study participants according to the need of h-CPAP.

Variables Room air or oxygen only h-CPAP application p-value
N = 31 N = 10
Timing of infection
1st wave (Mar-Aug 2020) 10 (32.2) 0 0.040
2nd wave (Sept-Dec 2020) 16 (51.6) 3 (30.0) 0.205
3rd wave (Jan-Mar 2021) 5 (16.1) 7 (70.0) 0.003
Demographic and obstetric variables
Maternal age (years) 31.6 ±4.9 33.3 ± 6.4 0.397
BAME 7 (22.6) 3 (30.0) 0.683
Pregestational BMI ≥30 Kg/m2 4 (12.9) 4 (40.0) 0.082
Comorbidities 6 (19.4) 1 (10.0) 0.660
Nulliparity 10 (32.3) 4 (40.0) 0.712
Pregnancy complications 15 (48.4) 6 (60.0) 0.719
GA at hospital admission (weeks) 31.4 ± 5.6 29.4 ± 5.0 0.318
Laboratory data at hospital admission
White blood cells (10^3/uL) 7.93 ± 3.3 9.49 ± 4.3 0.260
Lymphocytes (10^3/uL) 1.2 ± 0.6 1.1 ± 0.7 0.560
Platelets (10^3/uL) 202.1 ± 68.5 253.8 ± 125.3 0.125
D-dimer (ng/mL) 713.4 ± 801.5 651.0 ± 539.5 0.858
(n = 28) (n = 8)
Fibrinogen (mg/dL) 512.6 ±144.2 524.8 ± 157.4 0.839
ALT (U/L) 29.7 ± 34.8 38.9 ± 28.1 0.478
LDH (U/L) 185.3 ±39.3 213.0 ± 55.3 0.111
CRP (mg/dL) 3.0 ± 2.9 6.1 ± 4.4 0.021
Chest X-ray findings upon hospital admission
Involvement of ≥3 lobes 3 (9.7) 8 (80.0) <0.001
Bilateral involvement 14 (45.2) 10 (100.0) 0.002
Lobe involvement
    • Right Lower 19 (61.3) 10 (100.0) 0.021
    • Left Lower 13 (41.9) 10 (100.0) 0.002
    • Right middle 7 (22.6) 9 (90.0) <0.001
    • Lingula 8 (25.8) 9 (90.0) <0.001
    • Right Upper 1 (3.2) 3 (30.0) 0.039
    • Left Upper 5 (16.1) 2 (20.0) 1.000

Footnotes: Data shown as mean ± standard deviation or number (percentage).

BAME, Black, Asian, and minor ethnicity; BMI, Body Mass Index; h-CPAP, helmet continuous positive airway pressure; GA, gestational age.